BML Capital Management’s Mural Oncology MURA Stock Holding History
Bought
Maintained
Sold
BML Capital Management's MURA Position: Q4 2025 in Review
BML Capital Management sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 57,500 shares — an estimated $119K sold.
BML Capital Management first reported a position in MURA in Q3 2025 and held it in 1 quarter. The position peaked at $119K in Q3 2025. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.
- BML Capital Management reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
- BML Capital Management sold 57,500 Mural Oncology shares in Q4 2025, an estimated $119K.
- BML Capital Management first reported a position in Mural Oncology in Q3 2025 and held it in 1 quarter.
- BML Capital Management's Mural Oncology position peaked at $119K in Q3 2025.
- 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.
Based on BML Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.